[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371304-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371304-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-analysis-of-methyltransferase-like-16-mettl16-and-validated-in-colorectal-cancer-research-paper","Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer - Research Paper","","Human Methyltransferase-like 16 (METTL16) is an m6A methyltransferase reported to associate with multiple cancers, yet comparative evidence across diverse tumor types remains limited. This study evaluates METTL16 expression and links it to patient prognosis across malignancies using TIMER and human protein atlas datasets. Bioinformatics results show METTL16 overexpression in most tumors and prognostic relevance, especially in colorectal cancer (CRC). In vitro assays indicate that METTL16 downregulation reduces CRC proliferation and migration, supporting METTL16 as a prognostic biomarker and CRC functional contributor.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-analysis-of-methyltransferase-like-16-mettl16-and-validated-in-colorectal-cancer-research-paper/371304/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-analysis-of-methyltransferase-like-16-mettl16-and-validated-in-colorectal-cancer-research-paper/371304.png","ImageObject",300,407,{"name":42,"@type":43},"Asher","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is METTL16 and why is it relevant to cancer?","Question",{"text":63,"@type":64},"METTL16 is an m6A methyltransferase. Prior studies have linked METTL16 with certain cancers, motivating investigation of its broader role across tumor types.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was METTL16 evaluated across multiple cancers?",{"text":68,"@type":64},"The study used bioinformatics analyses of multiple cancer-related databases, including TIMER and human protein atlas, to assess METTL16 expression patterns and clinical prognosis associations.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence supports METTL16’s role in colorectal cancer?",{"text":72,"@type":64},"In vitro experiments showed that downregulating METTL16 expression reduces colorectal cancer cell proliferation and migration, indicating functional involvement in CRC.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371304,1791088690,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","[www.aging-us.com](www.aging-us.com) AGING 2025, Vol. 17, No. 2  \nResearch Paper  \nPan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer  \nLing Liu1,*, Siying Wang1,*, Xuyu Chen1,*, Qian Luo1, Zhaoxia Wang1, Juan Li1  \n1 Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210011, China  \n* Equal contribution  \nCorrespondence to: Juan Li, Zhaoxia Wang; email: [ljsmz1229@163.com](ljsmz1229@163.com), [https://orcid.org/0000-0002-7842-7130](https://orcid.org/0000-0002-7842-7130); [wangzhaoxia@njmu.edu.cn](wangzhaoxia@njmu.edu.cn)  \nKeywords: METTL16, pan-cancer, biomarker, colorectal cancer, tumorigenesis  \nReceived: May 10, 2024 Accepted: December 11, 2024 Published: February 27, 2025  \nCopyright: © 2025 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nHuman Methyltransferase-like 16(METTL16) is an independent N6-methyladenosine (m6A) methyltransferase. Previous studies have proven METTL16 been linked with some types of cancers. However, comparative studies of the relevance of METTL16 across diverse tumors remain sparse. We comprehensively investigated the effect of METTL16 expression on tumor prognosis across human malignancies by analyzing multiple cancer-related databases like Tumor Immune Estimation Resource (TIMER) and human protein atlas (HPA). Bioinformatics data indicated that METTL16 was overexpressed in most of these human malignancies and was significantly associated with the prognosis of patients with cancer, especially in colorectal cancer (CRC). Subsequently, In vitro experiments, the utility of METTL16 that downregulation of its expression could result in reduced proliferation and migration of CRC cells. Our findings reveal novel insights into METTL16 expression and its biological functions in diverse cancer types, indicating that METTL16 could serve as a prognostic biomarker and plays an important role in colorectal cancer.  \nINTRODUCTION  \nGastric cancer (GC) is a significant global health concern, annually affecting about one million individuals and resulting in approximately 769,000 deaths [1] . Genomic and epigenomic researches are crucial to better proper understanding and recognition of process of tumorigenesis. A pan-cancer analysis of novel genes will be helpful for playing a constructive role in cancer development.  \nMETTL16 (Methyltransferase-like 16) protein, also known as: METT10D, Gene ID: 79066, has recently been reported as an independent RNA methyltransferase [2] . N6-methyladenosine (m6A) is the most popular mRNA modification in mammals and has been involved in various biological processes. METTL16 is involved in this m6A Methylation regulation [3] . METTL16  \ncontrols abundant m6A installers by regulating Sadenosylmethionine (SAM) homeostasis to affect multiple aspects of human. The appearance of the m6Amethylation alters multiple biological processes and may result in cancer development and progression when it interacts tumor-related genes [4]. Similarly, METTL16 has been associated with many functions such as proliferation and differentiation in tumors. The METTL16 regulators have been connected with various types of cancers [5–8]. However, current studies only explored that METTL16 was linked to a few cancer types, and its biological role remains unexplored in most tumor types.  \nTo explore the expression state of METTL16 among various cancer types in a pan-cancer analysis, we concluded survival status, the subcellular distribution, genetic alteration and relevant molecular pathways. In the results, we found that METTL16 was highly  \n588  \nexpressed in colorectal cancer (CRC)and was associated with the prognosis of the disease, so we chose CRC asthe cancer to further explore. In vitro ","cbCaidZdUttoQaZB","https://ap.wps.com/l/cbCaidZdUttoQaZB","pdf",3131540,"English","# Abstract\n# Introduction\n# Materials and Methods\n## METTL16 expression analysis\n## Survival prognosis analysis\n## Immunohistochemistry (IHC) staining\n## Subcellular distribution\n## Immune infiltration analysis","[{\"question\":\"What is METTL16 and why is it relevant to cancer?\",\"answer\":\"METTL16 is an m6A methyltransferase. Prior studies have linked METTL16 with certain cancers, motivating investigation of its broader role across tumor types.\"},{\"question\":\"How was METTL16 evaluated across multiple cancers?\",\"answer\":\"The study used bioinformatics analyses of multiple cancer-related databases, including TIMER and human protein atlas, to assess METTL16 expression patterns and clinical prognosis associations.\"},{\"question\":\"What experimental evidence supports METTL16’s role in colorectal cancer?\",\"answer\":\"In vitro experiments showed that downregulating METTL16 expression reduces colorectal cancer cell proliferation and migration, indicating functional involvement in CRC.\"}]","Pan-cancer analysis of Methyltransferase-like 16 (METTL16) and validated in colorectal cancer - Research Paper | PDF",1790191753,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ccca3f101cabfcd8b250fe8f92a3056.webp",983,1272,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc3997942146e07c5c3be5ee26dd85e9.webp",982,1270,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8005e356313aab7d8d630c1bde6df88e.webp",981,1269,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e33664d131ef4fd45512f65717ee6e17.webp",980,1268]